arrow_back Back to App

Improving Kidney Disease Care and Treatment Access

This act aims to enhance care for individuals with kidney disease. It introduces changes to facilitate early detection, increase access to kidney education, and improve the quality of dialysis treatment. Citizens with kidney disease will gain better access to health insurance and a broader range of services.
Key points
Early Detection: Kidney disease screenings will be included in annual Medicare wellness visits, helping to diagnose the condition earlier.
Increased Education Access: More individuals with kidney disease will be able to access education about their condition, and educational services will be available in more facilities.
Better Insurance Coverage: Individuals with end-stage renal disease, regardless of age, will have guaranteed access to supplemental Medigap insurance, reducing their treatment costs.
Support for Innovation: The payment system for dialysis will be refined to better support new drugs, therapies, and technologies, potentially leading to improved treatment methods.
Kidney Disease Research: Studies will be conducted on kidney transplantation and the impact of kidney disease on minority populations, aiming to develop more effective treatment strategies.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_1971
Sponsor: Sen. Cardin, Benjamin L. [D-MD]
Process start date: 2021-06-08
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Chronic Kidney Disease Improvement in Research and Treatment Act of 2021

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_S_1971.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2021-06-08.

What are the main provisions?

Key points include:

  • Early Detection: Kidney disease screenings will be included in annual Medicare wellness visits, helping to diagnose the condition earlier.
  • Increased Education Access: More individuals with kidney disease will be able to access education about their condition, and educational services will be available in more facilities.
  • Better Insurance Coverage: Individuals with end-stage renal disease, regardless of age, will have guaranteed access to supplemental Medigap insurance, reducing their treatment costs.
  • Support for Innovation: The payment system for dialysis will be refined to better support new drugs, therapies, and technologies, potentially leading to improved treatment methods.
  • Kidney Disease Research: Studies will be conducted on kidney transplantation and the impact of kidney disease on minority populations, aiming to develop more effective treatment strategies.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Cardin, Benjamin L. [D-MD].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

CATEGORIES

Health